CoChat

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

Open access
Azzaoui, Imane, Uhel, Fabrice, Rossille, Delphine, Pangault, Celine, Dulong, Joelle, Le Priol, Jerome, Lamy, Thierry, Houot, Roch, Le Gouill, Steven, Cartron, Guillaume, Godmer, Pascal, Bouabdallah, Krimo, Milpied, Noel, Damaj, Gandhi, Tarte, Karin, Fest, Thierry, Roussel, Mikael · 2016 · Blood

The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.

Abstract

In diffuse large B-cell lymphoma (DLBCL), the number of circulating monocytes and neutrophils represents an independent prognostic factor. These cell subsets include monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) defined by their ability to suppress T-cell responses. MDSCs are a heterogeneous population described in inflammatory and infectious diseases and in numerous tumors including multiple myeloma, chronic lymphocytic leukemia, and DLBCL. However, their mechanisms of action remain unclear. We broadly assessed the presence and mechanisms of suppression of MDSC subsets in DLBCL. First, a myeloid suppressive signature was identified by gene expression profiling in DLBCL peripheral blood. Accordingly, we identified, in a cohort of 66 DLBCL patients, an increase in circulating G-MDSC (Lin(neg)HLA-DR(neg)CD33(pos)CD11b(pos)) and M-MDSC (CD14(pos)HLA-DR(low)) counts. Interestingly, only M-MDSC number was correlated with the International Prognostic Index, event-free survival, and number of circulating Tregs. Furthermore, T-cell proliferation was restored after monocyte depletion. Myeloid-dependent T-cell suppression was attributed to a release of interleukin-10 and S100A12 and increased PD-L1 expression. In summary, we identified expanded MDSC subsets in DLBCL, as well as new mechanisms of immunosuppression in DLBCL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2015-08-662783

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 168

Metadata

Authors
Azzaoui, I., Uhel, F., Rossille, D., Pangault, C., Dulong, J., Le Priol, J., Lamy, T., Houot, R., Le Gouill, S., Cartron, G., Godmer, P., Bouabdallah, K., Milpied, N., Damaj, G., Tarte, K., Fest, T., & Roussel, M.
Affiliations
  • Pôle Biologie and
  • Inserm (FR)
  • Service d'Hématologie Clinique, Centre Hospitalier Universitaire de Nantes, Unité Mixte de Recherche 892 équipe 10, Nantes, France;
  • Centre Hospitalier Universitaire de Montpellier (FR)
  • Centre hospitalier Bretagne Atlantique (FR)
  • Centre Hospitalier Universitaire de Bordeaux (FR)
  • Centre Hospitalier Universitaire de Caen Normandie (FR)
Venue
Blood
Published
2016-08-25
Volume
128
Issue
8
Pages
1081-1092
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2470898142
Cited by
168
References
64
Citations by year
2026: 6 · 2025: 19 · 2024: 19 · 2023: 7 · 2022: 22 · 2021: 26 · 2020: 24 · 2019: 8 · 2018: 16 · 2017: 19 · 2016: 2
FWCI
9.08
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Institut National Du Cancer
  • Université de Montpellier
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
Keywords
diffuse large B-cell lymphoma, myeloid-derived suppressor cells, T cell suppression, granulocytic MDSCs, immunosuppression, IL-10, S100A12, PD-L1, regulatory T cells, International Prognostic Index, prognostic factors, T cell proliferation
MeSH terms
S100A12 Protein, Myeloid-Derived Suppressor Cells, Arginase, Humans, Immunosuppression Therapy, Monocytes, T-Lymphocytes, Gene Expression Regulation, Neoplastic, Lymphoma, Large B-Cell, Diffuse, Interleukin-10, Gene Expression Profiling, Cell Proliferation, Indoleamine-Pyrrole 2,3,-Dioxygenase, Transcriptome, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. https://app.cochat.ai/papers/10.1182/blood-2015-08-662783
The paper
Azzaoui, I., Uhel, F., Rossille, D., Pangault, C., Dulong, J., Le Priol, J., Lamy, T., Houot, R., Le Gouill, S., Cartron, G., Godmer, P., Bouabdallah, K., Milpied, N., Damaj, G., Tarte, K., Fest, T., & Roussel, M. (2016). T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood. https://doi.org/10.1182/blood-2015-08-662783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.